Eosinopenia as a diagnostic marker in Covid-19 F Ajeneye, O Olofin Hematol Blood Disord 2020; 2 (1): 31-33. 32 Hematol Blood Disord 2020 Volume …, 2020 | 3 | 2020 |
Hypermanganesemia Revisited A Zeglam Hematology and Blood Disorders 3 (1), 25-27, 2020 | 1 | 2020 |
Future prospects for DLBCL treatment: Combination of WEE1 inhibitors with CHOP and radiation therapy LV Tom van Meerten, Mathilde Rikje Willemijn de Jong Hematology and Blood Disorders 3 (1), 21-22, 2020 | 1* | 2020 |
The critical push for traceability compliance: A District General Hospital experience. F Ajeneye Hematol Blood Disord 3 (1), 28-32, 2020 | 1 | 2020 |
Gemcitabine-carbon nitride dots as nanocarrier to target specifically pediatric glioma tumors PYL Roger M Leblanc* Hematology and Blood Disorders 3 (2), 33-35, 2020 | | 2020 |
Reduction of frequency of pain in clinical trial with association of arginine and hydroxyurea in sickle cell anemia's patients in Brazil REÃÂ rio Hematology and Blood Disorders 3 (1), 23-24, 2020 | | 2020 |
Comparing methods of tranexamic acid administration and blood reinfusion in reducing blood loss during total knee arthroplasty. GG Mingyang Yu, Bowu Luan, Simiao Tian Hematology and Blood Disorders 1 (1), 6-10, 2017 | | 2017 |
Next-generation sequencing: emerging technology in the area of hematology and blood disorder. PS Kedar Hematology and Blood Disorders 1 (1), 3-4, 2017 | | 2017 |
Survey of hemoglobinopathies in Central Vietnam: Identification of a novel ?-globin gene mutation (HBB:c.-122T>A) PM Monica Pirastru, Laura Manca, Chau Quynh Nguyen Hematology and Blood Disorders 2 (1), 13-15, 2017 | | 2017 |
Diagnosis of thrombotic thrombocytopenic purpura in low income country applicability of plasmic score. DS Oliveira Hematology and Blood Disorders 2 (1), 11-12, 2017 | | 2017 |
Testicular relapse in Acute Lymphoblastic Leukemia (ALL): A simple problem of common sense AG Martins | | |